Cargando…
OR09-3 11β-HSD1 Mediates a Partial Suppression of Muscle Atrophy in Chronic Inflammatory Disease in Response to Therapeutic Glucocorticoids
Objective: Therapeutic glucocorticoids (GCs) are routinely used in the treatment of chronic inflammatory disease due to their potent anti-inflammatory effects. Despite their efficacy, chronic exposure to GCs elicits undesirable side effects, including muscle atrophy (1). 11 beta-hydroxysteroid dehyd...
Autores principales: | Webster, Justine, Fenton, Chloe, Raza, Karim, Lavery, Gareth, Langen, Ramon, Hardy, Rowan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554818/ http://dx.doi.org/10.1210/js.2019-OR09-3 |
Ejemplares similares
-
SAT-003 Therapeutic Glucocorticoids Prevent Local and Systemic Bone Loss but Exacerbate Muscle Wasting When Administered in Chronic Inflammation
por: Fenton, Chloe, et al.
Publicado: (2019) -
ODP443 Targeting NAD+ availability modulates 11β- Hydroxysteroid dehydrogenase 1 activity in mouse and human cell lines and primary cells
por: Kabli, Ali, et al.
Publicado: (2022) -
SAT-734 HSD3B1 Expression in the Human Immune System
por: McManus, Jeffrey M, et al.
Publicado: (2020) -
One Hormone for Two Receptors: Exploring Glucocorticoid Actions Mediated by the Glucocorticoid and Mineralocorticoid Receptors
por: Petrillo, Maria G, et al.
Publicado: (2021) -
Glucocorticoid Mediated Transcriptional Activity in Human Corneal Epithelial Cells Lacking the Glucocorticoid Receptor
por: Jonsson, Andrea Joyce, et al.
Publicado: (2021)